• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异常的 p16、p53 和 Ki-67 免疫组化染色模式可将单纯性角化棘皮瘤与皮肤鳞状细胞癌区分开来。

Aberrant p16, p53 and Ki-67 immunohistochemistry staining patterns can distinguish solitary keratoacanthoma from cutaneous squamous cell carcinoma.

机构信息

Cellular Pathology, South Warwickshire NHS Foundation Trust, Warwick, UK.

Cellular Pathology, South Warwickshire NHS Foundation Trust, Warwick, UK.

出版信息

Pathology. 2023 Oct;55(6):772-784. doi: 10.1016/j.pathol.2023.07.001. Epub 2023 Jul 20.

DOI:10.1016/j.pathol.2023.07.001
PMID:37573161
Abstract

Keratoacanthoma (KA) is widely considered a benign, usually self-resolving, neoplasm distinct from cutaneous squamous cell carcinoma (cSCC), while some consider KA to be indistinguishable from cSCC. Published studies indicate utility for p16, p53, Ki-67 immunostaining and elastic van Gieson (EVG) in the assessment of KA and cSCC. We compared clinical features and staining patterns for p16, p53, Ki-67 and EVG in fully excised KA, cSCC with KA-like features (cSCC-KAL) and other cSCC (cSCC-OTHER). Significant differences between KA, cSCC-KAL and cSCC-OTHER were found for head and neck location (20%, 86%, 84%), and duration <5 months (95%, 63%, 36%). KA shows both a mosaic pattern for p16 (>25-90% of neoplasm area) and peripheral graded pattern for p53 (up to 50% moderate and strong nuclear staining) in 92% compared with 0% of cSCC-KAL and 0% of cSCC-OTHER. In contrast, a highly aberrant pattern (usually null) for one or both p16 and p53, was present in 0% of KA, 83.8% of cSCC-KAL and 90.9% of cSCC-OTHER. Abnormal distribution of Ki-67 beyond the peripheral 1-3 cells was uncommon in KA (4.2%) and common in cSCC-KAL (67.6%) and cSCC-OTHER (88.4%). Moderate to striking entrapment of elastic and collagen fibres was present in the majority of KA (84%), cSCC-KAL (81%) and cSCC-OTHER (65%). KA are clinically distinct neoplasms typically of short duration occurring preferentially outside the head and neck and generally lacking aberrations of p16, p53 and Ki-67, compared with cSCC that have high rates of aberrant or highly aberrant p16, p53 and Ki-67, but EVG lacked specificity.

摘要

角化棘皮瘤(KA)通常被认为是一种良性、通常可自行消退的肿瘤,与皮肤鳞状细胞癌(cSCC)不同,而有些则认为 KA 与 cSCC 无法区分。已发表的研究表明,p16、p53、Ki-67 免疫染色和弹性 van Gieson(EVG)在评估 KA 和 cSCC 方面具有实用性。我们比较了完全切除的 KA、具有 KA 样特征的 cSCC(cSCC-KAL)和其他 cSCC(cSCC-OTHER)的 p16、p53、Ki-67 和 EVG 的临床特征和染色模式。KA、cSCC-KAL 和 cSCC-OTHER 在头颈部位置(20%、86%、84%)和<5 个月(95%、63%、36%)方面存在显著差异。KA 显示 p16(>25-90%的肿瘤区域)的马赛克模式和 p53(高达 50%的中度和强核染色)的外周分级模式,而 cSCC-KAL 为 0%,cSCC-OTHER 为 0%。相比之下,0%的 KA、83.8%的 cSCC-KAL 和 90.9%的 cSCC-OTHER 存在一种或两种 p16 和 p53 的高度异常模式(通常为阴性)。Ki-67 在外周 1-3 个细胞之外的异常分布在 KA 中不常见(4.2%),而在 cSCC-KAL(67.6%)和 cSCC-OTHER(88.4%)中很常见。弹性纤维和胶原纤维的中度至显著捕获在大多数 KA(84%)、cSCC-KAL(81%)和 cSCC-OTHER(65%)中都有。与具有高异常或高度异常 p16、p53 和 Ki-67 的 cSCC 相比,KA 是临床上明显不同的肿瘤,通常持续时间较短,优先发生在头颈部以外,通常缺乏 p16、p53 和 Ki-67 的异常,而 EVG 缺乏特异性。

相似文献

1
Aberrant p16, p53 and Ki-67 immunohistochemistry staining patterns can distinguish solitary keratoacanthoma from cutaneous squamous cell carcinoma.异常的 p16、p53 和 Ki-67 免疫组化染色模式可将单纯性角化棘皮瘤与皮肤鳞状细胞癌区分开来。
Pathology. 2023 Oct;55(6):772-784. doi: 10.1016/j.pathol.2023.07.001. Epub 2023 Jul 20.
2
Computer Image Analysis Reveals C-Myc as a Potential Biomarker for Discriminating between Keratoacanthoma and Cutaneous Squamous Cell Carcinoma.计算机图像分析显示 C-Myc 可作为鉴别角化棘皮瘤和皮肤鳞状细胞癌的潜在生物标志物。
Biomed Res Int. 2022 Aug 23;2022:3168503. doi: 10.1155/2022/3168503. eCollection 2022.
3
Distinguishing Keratoacanthoma from Well-Differentiated Cutaneous Squamous Cell Carcinoma Using Single-Cell Spatial Pathology.利用单细胞空间病理学鉴别角化棘皮瘤与分化良好的皮肤鳞状细胞癌。
J Invest Dermatol. 2023 Dec;143(12):2397-2407.e8. doi: 10.1016/j.jid.2023.06.192. Epub 2023 Jul 5.
4
Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.角化棘皮瘤与鳞状细胞癌。对角化棘皮瘤样肿瘤中p53蛋白和增殖细胞核抗原表达的免疫组织化学重新评估。
Am J Dermatopathol. 1995 Aug;17(4):324-31. doi: 10.1097/00000372-199508000-00003.
5
The role of p53, Ki-67 and laminin expression in the differential diagnosis of keratoacanthoma and well-differentiated SCC.p53、Ki-67和层粘连蛋白表达在角化棘皮瘤与高分化鳞状细胞癌鉴别诊断中的作用
Indian J Pathol Microbiol. 2019 Oct-Dec;62(4):561-565. doi: 10.4103/IJPM.IJPM_752_18.
6
Expression of PD-L1 in keratoacanthoma and different stages of progression in cutaneous squamous cell carcinoma.角化棘皮瘤及皮肤鳞状细胞癌不同进展阶段中PD-L1的表达
Cancer Immunol Immunother. 2017 Sep;66(9):1199-1204. doi: 10.1007/s00262-017-2015-x. Epub 2017 May 13.
7
p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.皮肤角化棘皮瘤和鳞状细胞癌中p16的表达:一项免疫组织化学研究
Arch Pathol Lab Med. 2006 Jan;130(1):69-73. doi: 10.5858/2006-130-69-PEIKAS.
8
Solitary keratoacanthoma: a self-healing proliferation that frequently becomes malignant.孤立性角化棘皮瘤:一种常发生恶变的自愈性增殖病变。
Am J Dermatopathol. 2000 Aug;22(4):305-10. doi: 10.1097/00000372-200008000-00002.
9
The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma.与角化棘皮瘤相比,凋亡抑制因子Bcl-xL在皮肤鳞状细胞癌中优先表达。
Int J Cancer. 2009 May 15;124(10):2361-6. doi: 10.1002/ijc.24197.
10
A pilot study of p53 immunohistochemistry in atypical squamous lesions, using a vulvar scoring system.采用外阴评分系统对非典型鳞状上皮病变进行 p53 免疫组化的初步研究。
J Cutan Pathol. 2024 May;51(5):379-386. doi: 10.1111/cup.14591. Epub 2024 Feb 5.

引用本文的文献

1
Rapidly Enlarging Forearm Nodule Representing Keratoacanthoma-Type Crateriform Squamous Cell Carcinoma in a 54-Year-Old Man: A Case Report.
Cureus. 2025 Jul 30;17(7):e89039. doi: 10.7759/cureus.89039. eCollection 2025 Jul.
2
Clinicopathological comparison of eccrine poroma and porocarcinoma: Ki-67 index is not a decisive factor.小汗腺汗孔瘤与汗孔癌的临床病理比较:Ki-67指数并非决定性因素。
PLoS One. 2025 May 30;20(5):e0324975. doi: 10.1371/journal.pone.0324975. eCollection 2025.
3
Clinical and histopathological features of advanced cutaneous squamous cell carcinoma with varying responses to cemiplimab.对西米普利单抗有不同反应的晚期皮肤鳞状细胞癌的临床和组织病理学特征
J Dtsch Dermatol Ges. 2025 Jan;23(1):30-37. doi: 10.1111/ddg.15551. Epub 2024 Nov 3.
4
The 2023 WHO updates on skin tumors: advances since the 2018 edition.2023 年世卫组织皮肤肿瘤更新:自 2018 年版以来的进展。
Pathologica. 2024 Aug;116(4):193-206. doi: 10.32074/1591-951X-1006.
5
High incidence of HPV infection in minors with oral squamous cell carcinoma.未成年人口腔鳞状细胞癌中 HPV 感染的高发率。
Diagn Pathol. 2024 Mar 9;19(1):51. doi: 10.1186/s13000-024-01470-9.